Directly impacts IP practice by highlighting the critical role of bronchoscopic sampling techniques in providing adequate tissue for molecular profiling.
Abstract
In low- and middle-income countries(LMICs), barriers to early lung cancer(LC) detection extend beyond CT scanner availability to encompass participant identification pathways, digital management infrastructure, multidisciplinary coordination, and workforce capacity. Ethiopia's high tuberculosis burden, widespread biomass fuel exposure, and centralized oncology services create a distinct implementation environment. This report describes implementation and operational lessons from the first integrated LDCT-based early LC detection program in Ethiopia.
Keep reading
N opens the next oneHighlights the critical importance of obtaining adequate tissue via bronchoscopic biopsies for comprehensive molecular profiling.
Relevant to ablative therapies often managed or co-evaluated by interventional pulmonologists in the multidisciplinary management of lung malignancies.
Relevant for IP specialists involved in the bronchoscopic and image-guided tissue diagnosis and staging of apical lung masses.
Relevant to IP practices managing pulmonary nodules discovered during staging or diagnostic workups.
Highlights the critical role of EBUS-TBNA and mediastinoscopy in clinical trial quality control and accurate lung cancer staging.